SMTL ID : 7q9i.1

Beta-43 fab in complex with SARS-CoV-2 beta-Spike glycoprotein

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

hetero-3-3-3-mer

Ligands

12 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.1: 4 residues within 4Å: Chain A: N.714, L.919, Q.923, Q.1068 No protein-ligand interaction detected (PLIP) NAG-NAG.2: 3 residues within 4Å: Chain A: N.798, S.800, Q.801 No protein-ligand interaction detected (PLIP) NAG-NAG.3: 4 residues within 4Å: Chain A: N.1095, T.1097, H.1098, F.1100 No protein-ligand interaction detected (PLIP) NAG-NAG.4: 1 residues within 4Å: Chain A: N.1131 No protein-ligand interaction detected (PLIP) NAG-NAG.5: 4 residues within 4Å: Chain B: N.714, L.919, Q.923, Q.1068 1 PLIP interactions: 1 interactions with chain B Hydrophobic interactions: B:L.919 NAG-NAG.6: 2 residues within 4Å: Chain B: N.798, S.800 No protein-ligand interaction detected (PLIP) NAG-NAG.7: 4 residues within 4Å: Chain B: N.1095, T.1097, H.1098, F.1100 No protein-ligand interaction detected (PLIP) NAG-NAG.8: 1 residues within 4Å: Chain B: N.1131 No protein-ligand interaction detected (PLIP) NAG-NAG.9: 4 residues within 4Å: Chain C: N.714, L.919, Q.923, Q.1068 1 PLIP interactions: 1 interactions with chain C Hydrophobic interactions: C:L.919 NAG-NAG.10: 3 residues within 4Å: Chain C: N.798, S.800, Q.801 No protein-ligand interaction detected (PLIP) NAG-NAG.11: 4 residues within 4Å: Chain C: N.1095, T.1097, H.1098, F.1100 No protein-ligand interaction detected (PLIP) NAG-NAG.12: 1 residues within 4Å: Chain C: N.1131 No protein-ligand interaction detected (PLIP)

29 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.13: 2 residues within 4Å: Chain A: G.336, N.340 Ligand excluded by PLIP NAG.14: 2 residues within 4Å: Chain A: Y.28, N.61 Ligand excluded by PLIP NAG.15: 2 residues within 4Å: Chain A: N.277, N.279 Ligand excluded by PLIP NAG.16: 1 residues within 4Å: Chain A: N.600 Ligand excluded by PLIP NAG.17: 1 residues within 4Å: Chain A: N.613 Ligand excluded by PLIP NAG.18: 2 residues within 4Å: Chain A: H.652, N.654 Ligand excluded by PLIP NAG.19: 3 residues within 4Å: Chain A: N.706, G.1128 Chain B: D.793 Ligand excluded by PLIP NAG.20: 1 residues within 4Å: Chain A: N.1071 Ligand excluded by PLIP NAG.21: 1 residues within 4Å: Chain A: N.165 Ligand excluded by PLIP NAG.22: 1 residues within 4Å: Chain A: N.328 Ligand excluded by PLIP NAG.23: 2 residues within 4Å: Chain B: Y.28, N.61 Ligand excluded by PLIP NAG.24: 1 residues within 4Å: Chain B: N.279 Ligand excluded by PLIP NAG.25: 3 residues within 4Å: Chain B: N.328, I.329, Q.577 Ligand excluded by PLIP NAG.26: 1 residues within 4Å: Chain B: N.600 Ligand excluded by PLIP NAG.27: 1 residues within 4Å: Chain B: N.613 Ligand excluded by PLIP NAG.28: 2 residues within 4Å: Chain B: H.652, N.654 Ligand excluded by PLIP NAG.29: 3 residues within 4Å: Chain B: N.706, G.1128 Chain C: D.793 Ligand excluded by PLIP NAG.30: 2 residues within 4Å: Chain B: A.703, N.1071 Ligand excluded by PLIP NAG.31: 1 residues within 4Å: Chain B: N.165 Ligand excluded by PLIP NAG.32: 2 residues within 4Å: Chain B: F.339, N.340 Ligand excluded by PLIP NAG.33: 2 residues within 4Å: Chain C: Y.28, N.61 Ligand excluded by PLIP NAG.34: 2 residues within 4Å: Chain B: K.555 Chain C: N.279 Ligand excluded by PLIP NAG.35: 1 residues within 4Å: Chain C: N.600 Ligand excluded by PLIP NAG.36: 2 residues within 4Å: Chain C: N.613, Q.641 Ligand excluded by PLIP NAG.37: 2 residues within 4Å: Chain C: H.652, N.654 Ligand excluded by PLIP NAG.38: 3 residues within 4Å: Chain A: D.793 Chain C: N.706, G.1128 Ligand excluded by PLIP NAG.39: 3 residues within 4Å: Chain C: A.703, E.1069, N.1071 Ligand excluded by PLIP NAG.40: 2 residues within 4Å: Chain C: N.328, Q.577 Ligand excluded by PLIP NAG.41: 1 residues within 4Å: Chain C: N.340 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Liu, C. et al., The antibody response to SARS-CoV-2 Beta underscores the antigenic distance to other variants. Cell Host Microbe (2022)

Release Date

2021-12-15

Peptides

Spike glycoprotein: ABC
Beta-43 heavy chain: DFH
Beta-43 light chain: EGI

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

D
H

F
E

H
J

E
L

G
F

I
K

Spike glycoprotein

Beta-43 heavy chain

Beta-43 light chain

Related Entries With Identical Sequence